Evolus (EOLS) Amortizatization of Intangibles (2019 - 2021)
Evolus' (EOLS) quarterly Amortizatization of Intangibles came in at -$272000.0 in Q4 2021, down 3985.71% YoY from $7000.0 in Q4 2020, and down 3985.71% on a QoQ basis from $7000.0 in Q4 2020.
Evolus (EOLS) Amortizatization of Intangibles (2019 - 2021) Analysis & Trends
Evolus (EOLS) has 3 years of Amortizatization of Intangibles data on file, last reported at -$272000.0 in Q4 2021.
- Quarterly Amortizatization of Intangibles fell 3985.71% year-over-year to -$272000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$272000.0 (down 163.7% YoY) and the FY2021 annual result came in at -$272000.0, down 163.7% from the prior year.
- Amortizatization of Intangibles fell to -$272000.0 in Q4 2021, from $7000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $466000.0 in Q2 2019 to a low of -$272000.0 in Q4 2021.
- A 3-year average of $132555.6 and a median of $126000.0 in 2019 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2020 — Amortizatization of Intangibles surged 40.83% — and 2021, when it sank 3985.71%.
- Tracing EOLS's Amortizatization of Intangibles over 3 years: stood at $126000.0 in 2019, then sank by 94.44% to $7000.0 in 2020, then slumped by 3985.71% to -$272000.0 in 2021.
- The last three Amortizatization of Intangibles figures came in at -$272000.0 (Q4 2021), $7000.0 (Q4 2020), and $30000.0 (Q3 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Evolus | 550.51 Mn | 505.34 Mn | 57.18 Mn | 354,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -272,000.00 |
| Dec 31, 2021 | -272,000.00 |
| Dec 31, 2020 | 7,000.00 |
| Dec 31, 2020 | 7,000.00 |
| Sep 30, 2020 | 30,000.00 |
| Sep 30, 2020 | 30,000.00 |
| Jun 30, 2020 | 221,000.00 |
| Jun 30, 2020 | 221,000.00 |
| Mar 31, 2020 | 169,000.00 |
| Mar 31, 2020 | 169,000.00 |
| Dec 31, 2019 | 126,000.00 |
| Dec 31, 2019 | 126,000.00 |
| Sep 30, 2019 | 326,000.00 |
| Sep 30, 2019 | 326,000.00 |
| Jun 30, 2019 | 466,000.00 |
| Jun 30, 2019 | 466,000.00 |
| Mar 31, 2019 | 120,000.00 |
| Mar 31, 2019 | 120,000.00 |